IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 401 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $5,987,000 | +160.2% | 110,746 | +148.2% | 0.17% | +304.8% |
| Q3 2018 | $2,301,000 | -28.5% | 44,614 | -42.2% | 0.04% | -30.0% |
| Q2 2018 | $3,216,000 | +22.4% | 77,178 | +29.5% | 0.06% | 0.0% |
| Q1 2018 | $2,627,000 | +94.7% | 59,585 | +122.2% | 0.06% | +122.2% |
| Q4 2017 | $1,349,000 | +613.8% | 26,816 | +470.7% | 0.03% | +575.0% |
| Q1 2017 | $189,000 | -48.6% | 4,699 | -53.2% | 0.00% | -50.0% |
| Q3 2016 | $368,000 | -29.0% | 10,032 | -54.9% | 0.01% | -33.3% |
| Q2 2016 | $518,000 | +324.6% | 22,257 | +1026.4% | 0.01% | +500.0% |
| Q4 2015 | $122,000 | – | 1,976 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |